Clinical Trial Update: Vinorelbine/Gemcitabine Versus Vinorelbine/Cisplatin in Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 trial comparing vinorelbine/gemcitabine to vinorelbine/cisplatin in metastatic breast cancer. The current status of the study is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN